ABBOTT LABORATORIES

(ABT)
  Report
Delayed Nyse  -  05/20 04:03:37 pm EDT
113.24 USD   +0.71%
05/20Biden says first shipments of baby formula flying in from Europe this weekend
RE
05/20Abbott Laboratories' Completes Recall of its Baby Formula Products in India, Reuters Reports
MT
05/20Abbott - NEW LATE-BREAKING DATA HIGHLIGHT ABBOTT STRUCTURAL HEART TRANSCATHETER VALVE THERAPIES
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

US to Require Insurers to Pay for At-Home COVID-19 Tests

01/11/2022 | 04:14am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES 0.71% 113.24 Delayed Quote.-19.54%
BECTON, DICKINSON AND COMPANY 0.46% 252.3 Delayed Quote.2.66%
ON SEMICONDUCTOR CORPORATION 0.70% 56.46 Delayed Quote.-16.87%
QUIDEL CORPORATION 1.61% 99.91 Delayed Quote.-25.99%
All news about ABBOTT LABORATORIES
05/20Biden says first shipments of baby formula flying in from Europe this weekend
RE
05/20Abbott Laboratories' Completes Recall of its Baby Formula Products in India, Reuters Re..
MT
05/20Abbott - NEW LATE-BREAKING DATA HIGHLIGHT ABBOTT STRUCTURAL HEART TRANSCATHETER VALVE T..
AQ
05/20Baby formula crunch in U.S. forces scramble to boost supplies
RE
05/20French Food Group Danone Boosts US Shipments of Baby Formula Amid Shortage
MT
05/19Abbott Laboratories Says New Data Show Positive Results for Heart Treatment Devices
MT
05/19New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies
PR
05/19Abbott Laboratories Announces New Late-Breaking Data Highlight Abbott Structural Heart ..
CI
05/18Biden invokes Defense Production Act to increase infant formula supply
RE
05/17United Airlines, Abbott rise; Walmart, Fluor fall
AQ
More news
Analyst Recommendations on ABBOTT LABORATORIES
More recommendations
Financials (USD)
Sales 2022 41 813 M - -
Net income 2022 6 805 M - -
Net Debt 2022 4 167 M - -
P/E ratio 2022 30,2x
Yield 2022 1,70%
Capitalization 198 B 198 B -
EV / Sales 2022 4,84x
EV / Sales 2023 4,81x
Nbr of Employees 113 000
Free-Float 87,5%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Last Close Price 113,24 $
Average target price 137,43 $
Spread / Average Target 21,4%
EPS Revisions
Managers and Directors
Robert B. Ford Chairman, President, Chief Executive Officer & COO
Robert Emmett Funck Chief Financial Officer & Executive VP-Finance
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Glenn Fletcher Tilton Independent Director
William A. Osborn Lead Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES-19.54%198 277
MEDTRONIC PLC-0.89%137 548
BECTON, DICKINSON AND COMPANY2.66%71 922
HOYA CORPORATION-22.41%37 902
BAXTER INTERNATIONAL INC.-14.69%36 873
DEXCOM, INC.-40.18%31 521